Variation in treatment and outcomes of patients in hospital with acute myocardial infarction Post date 4 May 2022 ← PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events → PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction